326
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effect of oxygen pressure during incubation with a 10B-carrier on 10B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of 10B-carriers

, , , , , , , , , , & show all
Pages 187-194 | Received 21 Jul 2015, Accepted 26 Dec 2015, Published online: 18 Feb 2016

References

  • Barth RF, Coderre JA, Vicente MG, Blue TE. 2005. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res. 11:3987–4002.
  • Barth RF, Vicente MG, Harling OK, Kiger WS III, Riley KJ, Binns PJ, Wagner FM, Suzuki M, Aihara T, Kato I, et al. 2012. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer. Radiat Oncol. 7:146–166.
  • Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB. 1994. Neutron capture therapy of 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys. 30:643–652.
  • Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS III. 2003. Boron neutron capture therapy, cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat. 2:355–375.
  • Fei P, El-Deiry WS. 2003. P53 and radiation responses. Oncogene. 22:5774–5783.
  • Hall EJ, Giaccia AJ. 2012. Time, dose, and fractionation in radiotherapy. In: Hall EJ, Giaccia AJ, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins. pp 391–411.
  • Hamada N, Imaoka T, Masunaga S, Ogata T, Okayasu R, Takahashi A, Kato TA, Kobayashi Y, Ohnishi T, Ono K, et al. 2010. Recent advances in the biology of heavy-ion cancer therapy. J Radiat Res. 51:365–383.
  • Hammond EM, Dorie MJ, Giaccia AJ. 2003. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem. 278:12207–12213.
  • Hopewell JW, Morris GM, Schwint A, Coderre JA. 2011. The radiobiological principles of boron neutron capture therapy: A critical review. Appl Radiat Isot. 69:1756–1759.
  • Hopewell JW, Morris GM, Schwint A, Coderre JA. 2012. Boron neutron capture therapy: Application of radiobiological principles. In: Sauerwein W, Wittig A, Moss R, Nakagawa Y, editors. Neutron capture therapy. Principles and applications. Berlin: Springer-Verlag. pp 329–358.
  • Horsman MR, Wouters BG, Joiner MC, Overgaard J. 2009. The oxygen effect and fractionated radiotherapy. In: Joiner M, van der Kogel A, editors. Basic clinical radiobiology. 4th ed. London: Hodder Arnold. pp 207–216.
  • Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, et al. 1997. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog. 19:243–253.
  • Kobayashi T, Kanda K. 1983. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry. Nucl Instrum Methods. 204:525–531.
  • Kobayashi T, Sakurai Y, Kanda K, Fujita Y, Ono K. 2000. The remodeling and basic characteristics of the heavy water neutron irradiation facility of the Kyoto University Research Reactor, mainly for neutron capture therapy. Nucl Tech. 131:354–378.
  • Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M. 2001. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Int J Radiat Oncol Biol Phys. 51:828–839.
  • Masunaga S, Ono K. 2002. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res. 43:11–25.
  • Masunaga S, Ono K, Takahashi A, Ohnishi T, Kinashi Y, Takagaki M. 2002a. Radiobiological characteristics of solid tumours deoending on the p53 status of the tumour cells, with emphasis on the response of intratumor quiescent cells. Eur J Cancer. 38:718–727.
  • Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T. 2002b. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Jpn J Cancer Res. 93:1366–1377.
  • Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Liu Y, Kondo N, Maruhashi A, Kinashi Y, Ono K. 2012. Effects of employing a 10B-carrier and manipulating intratumor hypoxia on local tumor response and lung metastatic potential in boron neutron capture therapy. Br J Radiol. 85:249–258.
  • Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, et al. 2005. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages. J Neurosurg. 103:1000–1009.
  • Moulder JE, Rockwell S. 1984. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis and a survey of existing data. Int J Radiat Oncol Biol Phys. 10:695–712.
  • Ohnishi K, Wang X, Takahashi A, Ohnishi T. 1998. Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp Cell Res. 238:399–406.
  • Overgaard J, Hansen HS, Andersen AP, Hjelm-Hansen M, Jørgensen K, Sandberg E, Berthelsen A, Hammer R, Pedersen M. 1989. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys. 16:1065–1068.
  • Sakurai Y, Kobayashi T. 2000. Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instr Meth A. 453:569–596.
  • Sannigrahi MK, Singh V, Sharma R, Panda NK, Khullar M. 2015. Role of autophagy in head and neck cancer and therapeutic resistance. Oral Disease. 21:283–291.
  • Sigal A, Rotter V. 2000. Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 60:6788–6793.
  • Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Parry Howells G, Tipton I. 1975. Gross and elemental content of reference man. In: Snyder WS, editor. Report of the task group on reference man. Oxford, UK: Pergamon. pp 273–324.
  • Soloway AH, Hatanaka H, Davis MA. 1967. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J Med Chem. 10:714–717.
  • Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, Kimura Y, Ariyoshi Y, Haginomori S, Sakurai Y, et al. 2014. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res. 55:146–153.
  • Takahashi K, Sakamoto K, Kimura J. 2012. Hypoxic stress induces transient receptor potential melastatin 2 (TRPM2) channel expression in adult rat cardiac fibroblasts. J Pharmacol Sci. 118:186–197.
  • Toustrup K, Sørensen BS, Alsner J, Overgaard J. 2012. Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Semin Radiat Oncol. 22:119–127.
  • Vaupel P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 14:198–206.
  • Wittig A, Sauerwein WA, Coderre JA. 2000. Mechanisms of transport of p-boronophenylalanine through the cell membrane in vitro. Radiat Res. 153:173–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.